Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN118955421B introduces a silica gel stirring purification method for Pemafibrate intermediate, replacing column chromatography to ensure high purity and scalability.
Patent CN108069846B reveals a novel resolution method for cis-1-hydroxy-[1,1'-bis(cyclohexyl)]-2-carboxylic acid, eliminating precious metal catalysts for cost-effective pharmaceutical intermediate manufacturing.
Patent CN110655491B reveals a safer, high-yield route for 2-aminopyrimidine-5-carboxylate, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel copper-catalyzed route for Hydroxynisone. Safer demethylation, higher yield, scalable for liver fibrosis drug manufacturing.
Patent CN117305200A reveals efficient recombinant bacteria route. Offers scalable production and cost advantages for global pharmaceutical supply chains.
Patent CN102329256B reveals a metalloporphyrin catalytic oxidation method for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN109232441B reveals a POCl3-free route for 4-amino-2,6-dimethoxypyrimidine. Discover cost-effective, scalable manufacturing for sulfadimethoxine intermediates.
Advanced nitro-reduction pathway for S-Pregabalin offers safer scalable manufacturing and significant cost reduction in API production without high-pressure carbon monoxide.
Patent CN103896816B details iridium-catalyzed synthesis offering high enantioselectivity and scalable production for pharmaceutical intermediates.
Patent CN102365272B reveals a safer bromination method for Rosuvastatin intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Fe-catalyzed asymmetric synthesis of Bakuchiol. High yield, scalable process. Reliable supplier for pharmaceutical intermediates. Cost-effective manufacturing solution.
Patent CN114507186A reveals a safer Eltrombopag synthesis avoiding hydrogenation. Discover cost-effective, high-purity manufacturing solutions for supply chain optimization.
Patent CN1078590C reveals a catalytic hydrogenation route for 2-oxindole. Achieve cost reduction in API manufacturing with high-purity intermediates and scalable supply.
Patent CN112195203A details enzymatic synthesis of S-2-aminobutanamide. High purity, reduced costs, and scalable pharmaceutical intermediates manufacturing for global supply chains.
Advanced preparation of Sofosbuvir key intermediate via stable phosphorylation. Reduces cost and eliminates chromatography for reliable pharmaceutical intermediate supply.
Patent CN104788474B reveals metal-free synthesis for triazole benzothiazinone intermediates. Offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Advanced recrystallization patent for Hepatitis C drug intermediates. Delivers high-purity crystals, solvent recovery, and scalable manufacturing for global supply chains.
Novel patent CN117820190A enables high-yield synthesis of 4 6 dichloro pyrrolo pyridine intermediates ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN102643757B reveals a novel biocatalytic route for statin intermediates. Discover cost reduction and supply chain advantages for pharmaceutical manufacturing.
Discover a novel MnO2-catalyzed synthesis for Avatrombopag N-Oxide impurity. Enhanced yield and purity for reliable pharmaceutical intermediate supply chains.